Albert A.
Albert holds an MPhil in Economics from Oxford, an MFA in Fiction from NYU, and a PhD, focused on the theory of comedy, from the University of New South Wales. He is a published novelist and a playwright.
Simran
Simran is pursuing a combined MD/PhD in the Harvard-MIT MD program and Immunology PhD program. Previously, she was a research technician at Fred Hutch, where she helped design novel protein-based cancer therapeutics and a SARS-CoV-2 vaccine.
John
John earned his PhD in Chemical Biology from Harvard. Prior to that, he graduated valedictorian with highest honors in Biochemistry from Muhlenberg (Phi Beta Kappa, Pi Mu). He is now a postdoc fellow at Dana Farber Cancer Institute.